Tata India Pharma & Healthcare Reg Gr
as of 26 May 2026, 17:30 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 9.87% |
| Divi's Laboratories Ltd | Healthcare | E | 5.92% |
| HealthCare Global Enterprises Ltd | Healthcare | E | 5.45% |
| Abbott India Ltd | Healthcare | E | 5.37% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 5.17% |
| Cipla Ltd | Healthcare | E | 5.07% |
| Rainbow Childrens Medicare Ltd | Healthcare | E | 4.23% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 4.06% |
| Mankind Pharma Ltd | Healthcare | E | 3.73% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 3.73% |
| Fortis Healthcare Ltd | Healthcare | E | 3.55% |
| Bayer CropScience Ltd | Basic Materials | E | 3.34% |
| Metropolis Healthcare Ltd | Healthcare | E | 3.07% |
| Syngene International Ltd | Healthcare | E | 2.94% |
| Lupin Ltd | Healthcare | E | 2.94% |
| Sai Life Sciences Ltd | Healthcare | E | 2.63% |
| Dr. Lal PathLabs Ltd | Healthcare | E | 2.60% |
| Alkem Laboratories Ltd | Healthcare | E | 2.49% |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | E | 2.44% |
| Neuland Laboratories Ltd | Healthcare | E | 2.41% |
| J.B. Chemicals & Pharmaceuticals Ltd | Healthcare | E | 2.21% |
| Global Health Ltd | Healthcare | E | 2.16% |
| FDC Ltd | Healthcare | E | 1.94% |
| Ajanta Pharma Ltd | Healthcare | E | 1.90% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 1.72% |
| Sanofi India Ltd | Healthcare | E | 1.68% |
| Procter & Gamble Health Ltd | Healthcare | E | 1.55% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 1.01% |
| Corona Remedies Ltd | Healthcare | E | 0.77% |
| Tata Chemicals Ltd | Basic Materials | E | 0.72% |
| PI Industries Ltd | Basic Materials | E | 0.70% |
| Aurobindo Pharma Ltd | Healthcare | E | 0.70% |
| HDFC Life Insurance Co Ltd | Financial Services | E | 0.67% |
| Sumitomo Chemical India Ltd Ordinary Shares | Basic Materials | E | 0.43% |
| Jubilant Pharmova Ltd | Healthcare | E | 0.36% |
| Dr Agarwal’s Health Care Ltd | Healthcare | E | 0.07% |
| Ipca Laboratories Ltd | Healthcare | E | 0.00288% |
| A) Repo | - | CR | 0.22% |
| Cash / Net Current Asset | - | C | 0.20% |
| Krishna Institute of Medical Sciences Ltd | - | E | - |
Equity / Debt / Cash Split
Equity
99.58%
Cash
0.42%
Equity sector allocation
Basic Materials
5.19%
Financial Services
0.67%
Healthcare
93.72%
Others
0.42%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.09%
63.78%
3Y Returns
+63.78%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.09%
63.78%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.09%
63.78%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+13.81%
Fund Manager
Rajat Srivastava
Risk Profile
Very High Risk
Expense Ratio
1.84%
Fund Size
₹1325.19 Cr
The Tata India Pharma & Healthcare Reg Gr has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 9.87% |
| Divi's Laboratories Ltd | 5.92% |
| HealthCare Global Enterprises Ltd | 5.45% |
| Abbott India Ltd | 5.37% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.17% |
| Cipla Ltd | 5.07% |
| Rainbow Childrens Medicare Ltd | 4.23% |
| Apollo Hospitals Enterprise Ltd | 4.06% |
| Mankind Pharma Ltd | 3.73% |
| Dr Reddy's Laboratories Ltd | 3.73% |
| Fortis Healthcare Ltd | 3.55% |
| Bayer CropScience Ltd | 3.34% |
| Metropolis Healthcare Ltd | 3.07% |
| Syngene International Ltd | 2.94% |
| Lupin Ltd | 2.94% |
| Sai Life Sciences Ltd | 2.63% |
| Dr. Lal PathLabs Ltd | 2.60% |
| Alkem Laboratories Ltd | 2.49% |
| GlaxoSmithKline Pharmaceuticals Ltd | 2.44% |
| Neuland Laboratories Ltd | 2.41% |
| J.B. Chemicals & Pharmaceuticals Ltd | 2.21% |
| Global Health Ltd | 2.16% |
| FDC Ltd | 1.94% |
| Ajanta Pharma Ltd | 1.90% |
| Vijaya Diagnostic Centre Ltd | 1.72% |
| Sanofi India Ltd | 1.68% |
| Procter & Gamble Health Ltd | 1.55% |
| Torrent Pharmaceuticals Ltd | 1.01% |
| Corona Remedies Ltd | 0.77% |
| Tata Chemicals Ltd | 0.72% |
| PI Industries Ltd | 0.70% |
| Aurobindo Pharma Ltd | 0.70% |
| HDFC Life Insurance Co Ltd | 0.67% |
| Sumitomo Chemical India Ltd Ordinary Shares | 0.43% |
| Jubilant Pharmova Ltd | 0.36% |
| Dr Agarwal’s Health Care Ltd | 0.07% |
| Ipca Laboratories Ltd | 0.00% |
| A) Repo | 0.22% |
| Cash / Net Current Asset | 0.20% |
| Krishna Institute of Medical Sciences Ltd | - |
The Tata India Pharma & Healthcare Reg Gr has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 5.19% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | 0.67% |
| Healthcare | 93.72% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Tata India Pharma & Healthcare Reg Gr:
The exit load of Tata India Pharma & Healthcare Reg Gr is as follows:
Exit load of 0.3%, if redeemed within 1 year
.The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy